Researchers develop test for osteoarthritis

Diagnosing the cause of joint pain can be difficult at times. There are a range of arthritic conditions, and identifying the right one plays an important role in a doctor's ability to recommend the appropriate treatment. In order to address this problem, a team of researchers from the Henry Ford Hospital may have developed a new test that accurately spots osteoarthritis.

The researchers found that the levels of two molecules called non-coding RNA accurately predict the amount of cartilage damage a person has experienced as a result of osteoarthritis. This could help doctors determine if a patient requires a prescription to buy Celebrex.

"Our results suggest we have identified a long-awaited biomarker for this leading cause of disability," said Gary Gibson, who led the study. "Developing a biomarker for osteoarthritis has been very elusive, but we believe our work shows great promise."

Osteoarthritis is generally a result of the aging process and wear and tear on joints. It is exceedingly common, particularly among seniors. A new test to identify those suffering from the condition holds the promise of making effective treatments available to those who need them the most.